2024 Financial Figures
Financial figures | T001 | |||
---|---|---|---|---|
2024 | 2023 | Change in %4 | ||
Order situation | ||||
Order book1 | EUR millions | 473.2 | 530.0 | -10.7 |
Income statement | ||||
Revenue | EUR millions | 1,155.1 | 1,222.8 | -5.5 |
Cost of materials ratio | % | 43.3 | 45.0 | n / a |
Personnel cost ratio | % | 29.3 | 26.3 | n / a |
Adjusted EBIT2 | EUR millions | 92.3 | 97.5 | -5.3 |
Adjusted EBIT margin2 | % | 8.0 | 8.0 | n / a |
EBIT | EUR millions | 57.3 | 76.1 | -24.7 |
EBIT margin | % | 5.0 | 6.2 | n / a |
Financial result | EUR millions | -23.3 | -22.7 | n / a |
Adjusted tax rate | % | 40.8 | 41.3 | n / a |
Adjusted profit for the period2 | EUR millions | 40.9 | 43.9 | -6.8 |
Adjusted earnings per share2 | EUR | 1.28 | 1.37 | -6.9 |
Profit for the period | EUR millions | 14.8 | 27.9 | -47.0 |
Earnings per share | EUR | 0.46 | 0.87 | -47.1 |
NORMA Value Added (NOVA) | EUR millions | -38.8 | -43.6 | n / a |
Return on Capital Employed (ROCE)3 | % | 8.8 | 9.3 | n / a |
Balance sheet1 | ||||
Total assets | EUR millions | 1,436.6 | 1,493.3 | -3.8 |
Equity | EUR millions | 721.4 | 693.4 | 4.0 |
Equity ratio | % | 50.2 | 46.4 | n / a |
Net debt | EUR millions | 329.2 | 345.4 | -4.7 |
Cash flow | ||||
Cash flow from operating activities | EUR millions | 137.0 | 118.9 | 15.2 |
Cash flow from investing activities | EUR millions | -63.5 | -59.8 | n / a |
Cash flow from financing activities | EUR millions | -114.1 | -57.9 | n / a |
Net operating cash flow | EUR millions | 105.4 | 87.3 | 20.7 |
1_Figures as at balance sheet date Dec 31. 2_Adjusted for effects from purchase price allocations. 3_Adjusted EBIT in relation to the average capital employed. 4_The percentage change is based on unrounded absolute figures. |
Non-financial figures | T002 | ||
---|---|---|---|
2024 | 2023 | ||
General information | |||
Core workforce1 | number | 6,041 | 5,994 |
Temporary workers1 | number | 1,553 | 2,011 |
Total workforce1 | number | 7,594 | 8,005 |
Invention applications | number | 25 | 20 |
Environment | |||
Total energy consumption | MWh | 128,440 | n / a2 |
Total energy consumption per net revenue associated with activities in high climate impact sectors | MWh/EUR thousands | 0.111 | n / a |
Generated energy | MWh | 25,694 | n / a |
Gross Scope 1 GHG emissions3 | tCO2eq | 5,163 | n / a |
Gross location-based Scope 2 GHG emissions | tCO2eq | 45,523 | n / a |
Gross market-based Scope 2 GHG emissions4 | tCO2eq | 30,794 | n / a |
Total Gross indirect (Scope 3) GHG emissions | tCO2eq | 1,066,280 | n / a |
Microplastics used5 | t | 36,526 | n / a |
Total water consumption | m3 | 167,106 | n / a |
Total amount of waste generated | t | 11,742 | n / a |
EU Taxonomy | |||
Taxonomy-eligible turnover | % | 26.0 | 24,5 |
Taxonomy-eligible CapEx | % | 28.4 | 40,3 |
Taxonomy-eligible OpEx | % | 26.4 | 13,6 |
Social | |||
Employees covered by collective agreements | % | 43.0 | n / a |
Employees represented by workers’ representatives (e.g. representation by works councils) | % | 9.0 | n / a |
Employees covered by the health and safety management system (ISO 45001) | % | 87.3 | n / a |
Fatalities as a result of work-related injuries | number | 0 | n / a |
Recordable work-related accidents | number | 77 | n / a |
Rate of recordable injuries | % | 4.97 | n / a |
Rate of recordable work-related illness | % | 0 | n / a |
1_Figures as of balance sheet date Dec 31. 2_n / a (not applicable); Due to the first-time application of the European Sustainability Reporting Standards (ESRS) and the resulting change in the calculation basis, it is not possible to provide information on the previous year for every KPI, as there is no comparability. 3_ In accordance with the GHG Protocol for all locations worldwide. 4_ In accordance with the GHG Protocol (market-based) for all locations worldwide. 5_ NORMA Group defines microplastics as small plastic particles that are less than 5 mm in size. Microplastics are sourced or used in products and leave NORMA Group's facilities as emissions, products or as a component of products and services. |
Non-financial figures (continued) | |||
---|---|---|---|
2024 | 2023 | ||
Days lost due to work-related injuries and work-related illnesses and, if available, the number of days lost due to fatalities as a result of such incidents | number | 1,730 | n / a |
Confirmed incidents of discrimination, human rights violations and severe human rights violations | number | 0 | n / a |
Fines, penalties and compensation for incidents of discrimination, human rights violations and severe human rights violations | EUR | 0 | n / a |
Preferred suppliers who have signed the Supplier Code of Conduct | % | 100 | n / a |
Incidents of non-compliance with the UN Guiding Principles on Business and Human Rights, the ILO Declaration on Fundamental Principles and Rights at Work or the OECD Guidelines for Multinational Enterprises | number | 0 | n / a |
Governance | |||
Violations of corruption and bribery regulations | number | 0 | n / a |
Fines for violations of corruption and bribery regulations | EUR | 0 | n / a |
Completion rate of the training on corruption | % | 96 | n / a |
Completion rate of the training on information security | % | 88 | n / a |
Number of defective parts per million parts produced | number | 3.2 | 2,2 |
Accepted customer complaints per month per production/distribution location | number | 2.8 | 3,91 |
Further non-financial key figures and descriptions of the calculation methodology can be found in the section CONSOLIDATED NON-FINANCIAL STATEMENT. | |||
Share data | |||
Initial public offering | April 2011 | ||
Stock exchange | Frankfurt Stock Exchange | ||
Market segment | Regulated Market (Prime Standard), SDAX | ||
ISIN | DE000A1H8BV3 | ||
Security identification number | A1H8BV | ||
Ticker symbol | NOEJ | ||
Highest price 20242 | EUR | 19.80 | |
Lowest price 20242 | EUR | 11.50 | |
Closing price2, 3 | EUR | 14.94 | |
Market capitalization3 | EUR millions | 476 | |
Dividend4 | EUR | 0.40 | |
Payout ratio4 | % | 31.2 | |
Number of shares issued | 31,862,400 | ||
1_Until 2023: Customer complaints per month per entity. 2_Xetra price. 3_Figures as at balance sheet date Dec 31. 4_Subject to approval by the Annual General Meeting on May 13, 2025. |
Legend
These contents are part of the Non-financial Group Report and were subject to a separate limited assurance examination.